tiprankstipranks
Advertisement
Advertisement
Caribou Biosciences reports Q4 EPS (28c) vs. (39c) last year
PremiumThe FlyCaribou Biosciences reports Q4 EPS (28c) vs. (39c) last year
1M ago
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
Premium
Market News
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
2M ago
Caribou Biosciences initiated with a Buy at Clear Street
Premium
The Fly
Caribou Biosciences initiated with a Buy at Clear Street
2M ago
FDA appoints Richard Pazdur as Director of CDER
PremiumThe FlyFDA appoints Richard Pazdur as Director of CDER
5M ago
Is CRBU a Buy, Before Earnings?
Premium
Pre-Earnings
Is CRBU a Buy, Before Earnings?
5M ago
Caribou Biosciences price target raised to $9 from $3 at H.C. Wainwright
Premium
The Fly
Caribou Biosciences price target raised to $9 from $3 at H.C. Wainwright
5M ago
Caribou Biosciences announces results from ANTLER phase 1 trial of vispa-cel
PremiumThe FlyCaribou Biosciences announces results from ANTLER phase 1 trial of vispa-cel
5M ago
Caribou Biosciences’ CRISPR-Edited CAR-T Therapy: A Promising Step in Multiple Myeloma Treatment
Premium
Company Announcements
Caribou Biosciences’ CRISPR-Edited CAR-T Therapy: A Promising Step in Multiple Myeloma Treatment
5M ago
Caribou Biosciences’ Long-Term Study: A Key Update for Investors
Premium
Company Announcements
Caribou Biosciences’ Long-Term Study: A Key Update for Investors
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100